Wolverine Asset Management LLC Boosts Stock Position in BlackRock Health Sciences Trust (NYSE:BME)

Wolverine Asset Management LLC raised its position in BlackRock Health Sciences Trust (NYSE:BME) by 360.1% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 60,108 shares of the company’s stock after acquiring an additional 47,044 shares during the quarter. Wolverine Asset Management LLC’s holdings in BlackRock Health Sciences Trust were worth $2,455,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently bought and sold shares of the business. Wells Fargo & Company MN grew its holdings in shares of BlackRock Health Sciences Trust by 10.6% in the fourth quarter. Wells Fargo & Company MN now owns 393,056 shares of the company’s stock valued at $15,903,000 after purchasing an additional 37,555 shares in the last quarter. 1607 Capital Partners LLC raised its position in BlackRock Health Sciences Trust by 95.0% in the 4th quarter. 1607 Capital Partners LLC now owns 171,742 shares of the company’s stock valued at $6,949,000 after purchasing an additional 83,650 shares in the last quarter. Cornerstone Advisory LLC boosted its stake in shares of BlackRock Health Sciences Trust by 15.4% in the 4th quarter. Cornerstone Advisory LLC now owns 118,744 shares of the company’s stock valued at $4,804,000 after buying an additional 15,861 shares during the period. Cambridge Investment Research Advisors Inc. grew its position in shares of BlackRock Health Sciences Trust by 4.3% during the second quarter. Cambridge Investment Research Advisors Inc. now owns 54,605 shares of the company’s stock worth $2,231,000 after buying an additional 2,240 shares in the last quarter. Finally, Raymond James & Associates increased its holdings in BlackRock Health Sciences Trust by 7.0% in the second quarter. Raymond James & Associates now owns 44,877 shares of the company’s stock valued at $1,833,000 after buying an additional 2,931 shares during the last quarter.

BlackRock Health Sciences Trust Stock Down 0.0 %

NYSE:BME opened at $42.40 on Wednesday. BlackRock Health Sciences Trust has a 1 year low of $35.53 and a 1 year high of $42.86. The stock has a 50-day simple moving average of $41.27 and a 200-day simple moving average of $40.74.

BlackRock Health Sciences Trust Dividend Announcement

The business also recently disclosed a monthly dividend, which was paid on Friday, August 30th. Shareholders of record on Thursday, August 15th were issued a dividend of $0.213 per share. The ex-dividend date was Thursday, August 15th. This represents a $2.56 dividend on an annualized basis and a yield of 6.03%.

BlackRock Health Sciences Trust Company Profile

BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services.